We are live on ! Find out more
ASTH icon

Astrana Health

105 hedge funds and large institutions have $645M invested in Astrana Health in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

562% more capital inflows, than outflows

Capital inflows: $175M | Capital outflows: $26.5M

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

133% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 18

38% more funds holding

Funds holding: 76 → 105 (+29)

3.62% more ownership

Funds ownership: 15.05% → 18.67% (+3.6%)

Holders
105
Holders Change
+29
Holders Change %
+38.16%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
42
Reduced
18
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ASTH Hedge Fund Activity: Q2 2021 in Review

105 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2021, worth a combined $645M — up 274% from $172M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ASTH positions and 9 closed out — a net gain of 29 holders — while 42 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $70.5M. The largest seller was Ophir Asset Management, cutting an estimated $9.03M.

  • 105 institutional investors held Astrana Health (ASTH) as of Q2 2021, up from 76 in Q1 2021.
  • Funds reported $645M of Astrana Health stock for Q2 2021, up 274% quarter-over-quarter.
  • 38 funds opened new Astrana Health positions in Q2 2021 and 9 closed out, a net change of +29 holders.
  • The largest Astrana Health buyer in Q2 2021 was BlackRock, an estimated $70.5M added.
  • The largest Astrana Health seller in Q2 2021 was Ophir Asset Management, an estimated $9.03M sold.

Based on aggregated 13F filings for Q2 2021.